drug
propranolol hydrochloride ER
Marketedupdated 3mo agoby Par Pharmaceutical Inc
Approvedcommunity read0 votes
🐶 often sniffed alongside
top 6Small molecule drug with a maximum clinical stage of Approval (across all indications), with 9 approved and 11 investigational indications.
indications
investigational
Hypertension
all catalysts(1)
Trials studying propranolol hydrochloride ER
- phase1Propranolol Hydrochloride in Combination With Sintilimab and Platinum-based Chemotherapy for Treatment of Advanced Non-small Cell Lung Cancer
- phase1Food Study of Propranolol Hydrochloride Extended-Release Capsules 160 mg and Inderal® LA Capsules 160 mg
- phase1Fasting Study of Propranolol Hydrochloride Extended-Release Capsules 160 mg and Inderal® LA Capsules 160 mg
Patent cliff
source: FDA Orange Bookfirst barrier falls
Oct 16, 2028
~2.2 years out
Earliest of all listed patents + FDA exclusivities. Generic / biosimilar entry typically only becomes possible AFTER both patent and exclusivity barriers expire.
patents (2)
- Oct 16, 2028method-of-use (U-1496)US 83384892.2y
- Oct 16, 2028method-of-use (U-1988)US 89872622.2y
News(0)
no news has mentioned this drug yet
Data sources
last refreshed 18m ago
Found something off?
comments(0)
5-min edit window · permanent after that